Avilion A A, Piatyszek M A, Gupta J, Shay J W, Bacchetti S, Greider C W
Cold Spring Harbor Laboratory, New York 11724, USA.
Cancer Res. 1996 Feb 1;56(3):645-50.
Telomerase activity has been detected in many human immortal cells lines and in tumor tissues, whereas it is generally absent from primary cell strains and from many tumor adjacent tissue samples. With the recently cloned human telomerase RNA (hTR), we used Northern analysis to follow the levels of hTR in primary, precrisis, and immortalized cells. It was surprising that the amount of hTR was high in cell strains that lacked telomerase activity, and the levels did not parallel the increases in telomerase activity, which accompanies immortalization. In addition, although the hTR levels were somewhat higher in tumor samples compared to nontumor tissues, the level of hTR in a variety of different human tumors did not predict the level of telomerase activity in the tumor. Thus, whereas hTR was detected in all samples that have telomerase activity, the presence of the RNA was not a good predictor of the presence or amount of telomerase activity.
在许多人类永生化细胞系和肿瘤组织中都检测到了端粒酶活性,而在原代细胞株和许多肿瘤邻近组织样本中通常不存在端粒酶活性。利用最近克隆的人类端粒酶RNA(hTR),我们通过Northern分析来追踪原代细胞、危机前细胞和永生化细胞中hTR的水平。令人惊讶的是,在缺乏端粒酶活性的细胞株中hTR的量很高,而且其水平与永生化过程中端粒酶活性的增加并不平行。此外,尽管与非肿瘤组织相比,肿瘤样本中的hTR水平略高,但在各种不同的人类肿瘤中,hTR的水平并不能预测肿瘤中端粒酶活性的水平。因此,虽然在所有具有端粒酶活性的样本中都检测到了hTR,但该RNA的存在并不能很好地预测端粒酶活性的存在或量。